Reviewed clinical summary · Source-linked · Educational use only

Can Social Networks Help Reduce Obesity? A Trial Protocol (ROBUST)

Hormone Insight clinical visual abstract for article 3815

Clinical Bottom Line

The ROBUST study protocol describes a planned randomized trial of a social network-enhanced lifestyle intervention for obesity in Black and Hispanic adults, with no outcome results yet. PICO summary and expert commentary.

Summary: This is the published protocol for the Reducing Obesity Using Social Ties (ROBUST) randomized controlled trial, not an outcomes paper. It describes a planned two-arm RCT in 132 Black or Hispanic adults with obesity (BMI at or above 30 kg/m squared), comparing a social network-enhanced lifestyle intervention against an individual-level lifestyle intervention. No weight-loss results are reported, because the trial had not yet been completed at publication.

PICO Summary

ElementDetail
PopulationPlanned enrolment of 132 adults who self-identify as Black or Hispanic and have obesity (BMI at or above 30 kg/m squared). Single-country trial (United States). Intervention participants are also asked to recruit up to two members of their personal social network (a further n=132 supporters).
InterventionTailored social network-enhanced lifestyle intervention modeled after the Diabetes Prevention Program: fourteen nutrition and lifestyle coaching sessions over 24 weeks, plus skill-building sessions designed to activate communal coping and address both positive and negative network influences. Arm size not pre-specified as a fixed split in the protocol abstract.
ComparisonIndividual-level lifestyle intervention (control): the same fourteen nutrition and lifestyle coaching sessions over 24 weeks, without the social network component.
OutcomeNo results reported. This is a protocol. Pre-specified measures (diet, physical activity, positive affect, social network processes, communal coping, and anthropometrics) are to be collected at baseline and at 24 weeks. No effect estimate, 95% CI, p value, ARR, or NNT is available, and none should be inferred. Prospectively registered (ClinicalTrials.gov NCT06335810).

Expert Commentary

The verdict is straightforward: ROBUST is a well-reasoned study protocol, and it proves nothing about efficacy yet. Any claim that a network-based approach “significantly enhanced” weight loss is unsupported, because no participant outcomes had been analysed at the time of publication. What the protocol does offer is a thoughtful design rationale. It targets Black and Hispanic adults, a group that has historically been under-served by standard lifestyle programmes, and it formalises the idea that a person’s social ties can either help or hinder weight loss, then tries to harness the helpful ones through communal coping. The single most important limitation is structural rather than a flaw in execution: a behavioural network intervention of this kind cannot be blinded, so participants and coaches know their allocation, which leaves room for performance and expectation effects that the eventual analysis will need to handle carefully. The planned sample of 132 is also modest for detecting anything beyond a fairly large between-arm difference. Can I use this with my patients? Not yet. There is no result to act on, only a plan. The sensible posture is to note the registration, await the 24-week outcomes, and judge the intervention on those data. I would encourage clinicians interested in social-support models to track NCT06335810 and read the results paper when it appears, rather than the protocol, before changing practice.

References

Phillips E, Potter C, Poole J, Lewis A, Nahid M, Christos P, et al. Reducing Obesity Using Social Ties (ROBUST): Protocol for a randomized control trial of a social network lifestyle intervention. PLoS One. 2025;20(4):e0318990. doi:10.1371/journal.pone.0318990

Educational use: Hormone Insight is intended for healthcare professionals and learners. Interpret each summary alongside the primary source, local guidance, and patient-specific clinical judgement.

Subscribe now

Welcome to Hormone Insight. Our mission is to support clinical decision-making with accessible, evidence-based insights from recent studies and trials.

© 2024-2026 Hormone Insight. All rights reserved.